Pathogenesis and epidemiology of neurotrophic keratopathy

被引:9
|
作者
Mertsch, S. [1 ,2 ]
Alder, J. [1 ]
Dua, H. S. [3 ]
Geerling, G. [1 ]
机构
[1] Heinrich Heine Univ Dusseldorf, Univ Klin Augenheilkunde, Moorenstr 5, D-40225 Dusseldorf, Germany
[2] Med Campus Univ Oldenburg, Pius Hosp Oldenburg, Univ Klin Augenheilkunde, Oldenburg, Germany
[3] Univ Nottingham, Acad Sect Ophthalmol, Div Clin Neurosci, Nottingham, England
来源
OPHTHALMOLOGE | 2019年 / 116卷 / 02期
关键词
Cornea; Innervation; Nerve regeneration; Degenerative corneal disease; Lacrimation; NERVE GROWTH-FACTOR; VIVO-CONFOCAL-MICROSCOPY; IN-SITU KERATOMILEUSIS; ENDOTHELIAL CORNEAL-DYSTROPHY; DRY EYE DISEASE; PENETRATING KERATOPLASTY; COLD THERMORECEPTORS; OCULAR SURFACE; SUBBASAL NERVES; TEAR PRODUCTION;
D O I
10.1007/s00347-018-0823-9
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Neurotrophic keratopathy (NK) is adegenerative corneal disease that is based on an impairment of the corneal innervation. The damage to the sensory innervation, which is delivered through the 1stbranch of the trigeminal nerve (ophthalmic nerve), can occur throughout the entire length of the nerve from the nucleus in the brainstem, e.g. caused by brain tumors, to the terminal nerve fibers in the cornea, caused for example by refractive corneal surgery (e.g. LASIK). Due to the loss of the sensory innervation, areduced lacrimation and areduction in the secretion of trophic factors occur. This in turn inhibits the regeneration potential of the corneal epithelium. In the most severe cases of the disease, the reduction or loss of lacrimation, together with the impaired regeneration potential of the epithelial cells, can lead to persistent epithelial defects, ulcers and corneal perforation. The NK has aprevalence of 5 or fewer individuals per 10,000 and is classified as arare, i.e. orphan disease (ORPHA137596). Afundamental understanding of the pathogenesis and epidemiology of NK supports the early diagnosis and therefore the initiation of aspecific treatment.
引用
收藏
页码:109 / 119
页数:11
相关论文
共 50 条
  • [21] Medical and surgical management of neurotrophic keratopathy
    Dua, Harminder S.
    ACTA OPHTHALMOLOGICA, 2024, 102
  • [22] Cacicol® - neurotrophic keratopathy in systematic review
    Kominek, E. Mrukwa
    Rokicki, D.
    ACTA OPHTHALMOLOGICA, 2016, 94
  • [23] Persistent epithelial defects in neurotrophic keratopathy
    Georgoudis, Panagiotis
    ACTA OPHTHALMOLOGICA, 2024, 102
  • [24] Etiologies and Clinical Outcomes of Neurotrophic Keratopathy
    Modi, D.
    Hsu, H. Y.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [25] Neurotrophic keratopathy: Update in diagnosis and management
    Font, Carlos Segundo
    Cortina, Maria Soledad
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2025, 73 (04) : 483 - 495
  • [26] Neurotrophic keratopathy Principles, diagnostics and treatment
    Mergler, Stefan
    Dietrich-Ntoukas, Tina
    Pleyer, Uwe
    OPHTHALMOLOGE, 2019, 116 (08): : 797 - 810
  • [27] Neurotrophic Keratopathy with Cavernous Sinus Pathology
    McElnea, E.
    Ryan, A.
    Fulcher, T.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2015, 184 : 450 - 450
  • [28] PREVALENCE OF NEUROTROPHIC KERATOPATHY IN THE UNITED KINGDOM
    Mildred, M.
    Van Nooten, F.
    Hudson, P.
    VALUE IN HEALTH, 2018, 21 : S424 - S424
  • [29] Amniotic Membrane Extract for Neurotrophic Keratopathy
    Liang, L.
    Sheha, H.
    Liu, Z.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [30] Neurotrophic keratopathy; its pathophysiology and treatment
    Okada, Yuka
    Reinach, Peter S.
    Kitano, Ai
    Shirai, Kumi
    Kao, Winston W. -Y.
    Saika, Shizuya
    HISTOLOGY AND HISTOPATHOLOGY, 2010, 25 (06) : 771 - 780